Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 12 | Olmstead NathanSVP and CFO | Tax withholding | F | $60K 2,988 sh | Jan 21, 2026 |
| 12 | Marquez OctavioDirector, President and CEO | Tax withholding | F | $219K 3,136 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 12 | DeSantis Dean10% Owner | Other acquisition or disposition | J | — 120.0K sh | Jan 21, 2026 traded Jan 20, 2026 |
| 11 | Piekos BrianChief Financial Officer | Grant or award | A | — 100.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 11 | Okupe OluyemiChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $275K 9,067 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 11 | Cree BrianPresident | Open-market sale · 10b5-1 plan | SELL | $28K 1,440 sh | Jan 21, 2026 traded Jan 21, 2026 |
| 11 | Tray ThomasPrincipal Accounting Officer | Grant or award | A | — 2,425 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 11 | Audhya Paul K.CHIEF MEDICAL OFFICER | Grant or award | A | — 100.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 11 | Sweeny NicoleChief Commercial Officer | Grant or award | A | — 100.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 11 | Smith DironEVP, Chief Financial Officer | Grant or award | A | — 7,091 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 11 | Mayes Patrick AEVP & Chief Scientific Officer | Grant or award | A | — 4,218 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 11 | Small MartinCFO & Senior Managing Director | Option exercise | M | — 27.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 11 | Issa Mohamed KhairieEVP, Head of US Oncology | Grant or award | A | — 14.2K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 10 | D'Amico AndrewDirector | Open-market sale · 10b5-1 plan | SELL | $31K 200 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 10 | Mat IshbiaDirector, President and CEO, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 6.60M sh | Jan 21, 2026 traded Jan 16, 2026 |
| 9 | Cambre JeromeVice President of Sales | Grant or award | A | — 40.7K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Cambre JeromeVice President of Sales | Grant or award | A | — 10.2K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Bowser Douglas SDirector | Grant or award | A | — 750 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Frey Anthony GeorgeSVP and Chief Revenue Officer | Tax withholding | F | $12K 610 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 9 | Moore MichaelPresident | Grant or award | A | — 118.8K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Vernon CarlaDirector | Grant or award | A | — 750 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Moore MichaelPresident | Grant or award | A | — 29.7K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Fitzgerald TraeChief Financial Officer | Grant or award | A | — 46.7K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Fitzgerald TraeChief Financial Officer | Grant or award | A | — 11.7K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Senn AndrewSVP, Strategy and Business Dev | Option exercise | M | — 363 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Frazier WilliamDirector, Chief Medical Officer | Grant or award | A | — 2,922 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Hoyt CaseyDirector, Chief Executive Officer | Grant or award | A | — 43.0K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Buss Jessica EDirector, Chief Executive Officer | Grant or award | A | — 941.2K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Hoyt CaseyDirector, Chief Executive Officer | Grant or award | A | — 172.2K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Frazier WilliamDirector, Chief Medical Officer | Grant or award | A | — 11.7K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Trahan JeremyGeneral Counsel | Grant or award | A | — 50.4K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Senn AndrewSVP, Strategy and Business Dev | Tax withholding | F | $31K 361 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Senn AndrewSVP, Strategy and Business Dev | Option exercise | M | — 2,224 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 9 | Senn AndrewSVP, Strategy and Business Dev | Option exercise | M | — 363 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Trahan JeremyGeneral Counsel | Grant or award | A | — 12.6K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Smith DironEVP, Chief Financial Officer | Option exercise | M | — 1,709 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 8 | Selecky ChristobelDirector | Option exercise · 10b5-1 plan | M | $149K 50.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 5 | Smith DironEVP, Chief Financial Officer | Option exercise | M | — 292 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 5 | Smith DironEVP, Chief Financial Officer | Tax withholding | F | $6,131 72 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 5 | Morrissey Michael JamesEVP, Head of Tech. Operations | Tax withholding | F | $44K 429 sh | Jan 21, 2026 traded Jan 20, 2026 |